Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970889 · ClinicalTrials.gov registry record · NA
Real-time Reminders To Decrease Late or Missed Meal Boluses
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03970889: Completed NA study, sponsored by Stanford University.
NCT03970889 is a NA study that has completed, run by Stanford University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03970889, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is examining whether the Klue app is effective in detecting missed or late meal boluses in patients with Type 1 diabetes. The app is programmed onto an Apple Watch and will detect potential missed boluses from hand motion. It will send text alerts to the user asking if they have bolused. This is a pilot study and will assess whether there is a change in the number of missed meal boluses in the two weeks prior to each visit. If the findings are significant, this software can be integrated in future closed-loop algorithms for automatic insulin delivery.
Interventions
- DEVICE Klue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-10-12 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03970889
The ClinicalTrials.gov registry entry for NCT03970889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Klue is the first listed.
NCT03970889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03970889 about?
NCT03970889 is a clinical study titled "Real-time Reminders To Decrease Late or Missed Meal Boluses". This study is examining whether the Klue app is effective in detecting missed or late meal boluses in patients with Type 1 diabetes. The app is programmed onto an Apple Watch and will detect potential missed boluses from hand motion. It will send text alerts to the user asking if they have bolused. ...
What is the current status of trial NCT03970889?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-10-12. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03970889?
The interventions under investigation include: Klue (DEVICE).
Who is sponsoring clinical trial NCT03970889?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.